Oppenheimer Holdings, Inc. Boosts LHC Group (LHCG) Price Target to $80.00
LHC Group (NASDAQ:LHCG) had its target price boosted by analysts at Oppenheimer Holdings, Inc. from $68.00 to $80.00 in a research report issued on Tuesday. The brokerage presently has an “outperform” rating on the health services provider’s stock. Oppenheimer Holdings, Inc.’s price target would indicate a potential upside of 13.41% from the company’s previous close.
Several other research analysts have also issued reports on the company. Royal Bank Of Canada reiterated a “buy” rating and issued a $69.00 price target on shares of LHC Group in a report on Tuesday, July 18th. BidaskClub lowered LHC Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 12th. Jefferies Group LLC restated a “buy” rating and issued a $68.00 target price on shares of LHC Group in a report on Friday, August 4th. Robert W. Baird restated a “hold” rating and issued a $63.00 target price on shares of LHC Group in a report on Tuesday, September 12th. Finally, Zacks Investment Research lowered LHC Group from a “buy” rating to a “hold” rating in a report on Wednesday, October 4th. Two equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. LHC Group currently has an average rating of “Buy” and a consensus price target of $74.60.
Shares of LHC Group (NASDAQ LHCG) traded down $1.28 during trading hours on Tuesday, reaching $70.54. The company’s stock had a trading volume of 246,060 shares, compared to its average volume of 143,431. The company has a market capitalization of $1,312.87, a price-to-earnings ratio of 32.21, a P/E/G ratio of 2.18 and a beta of 0.70. The company has a current ratio of 1.75, a quick ratio of 1.75 and a debt-to-equity ratio of 0.19. LHC Group has a 1-year low of $39.60 and a 1-year high of $76.14.
LHC Group (NASDAQ:LHCG) last announced its quarterly earnings results on Monday, November 6th. The health services provider reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.60 by $0.04. The business had revenue of $272.90 million for the quarter, compared to analyst estimates of $265.35 million. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The company’s quarterly revenue was up 18.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.54 earnings per share. equities research analysts expect that LHC Group will post 2.4 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: “Oppenheimer Holdings, Inc. Boosts LHC Group (LHCG) Price Target to $80.00” was first reported by Watch List News and is owned by of Watch List News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://www.watchlistnews.com/oppenheimer-holdings-inc-boosts-lhc-group-lhcg-price-target-to-80-00/1685890.html.
In other news, COO Donald Dwayne Stelly sold 2,650 shares of the firm’s stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $65.34, for a total value of $173,151.00. Following the transaction, the chief operating officer now owns 109,235 shares in the company, valued at $7,137,414.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 14.80% of the stock is owned by company insiders.
A number of institutional investors have recently modified their holdings of LHCG. UBS Asset Management Americas Inc. bought a new stake in LHC Group during the first quarter worth $248,000. Principal Financial Group Inc. lifted its holdings in LHC Group by 3.6% during the first quarter. Principal Financial Group Inc. now owns 113,707 shares of the health services provider’s stock worth $6,129,000 after acquiring an additional 3,983 shares during the period. Legal & General Group Plc lifted its holdings in LHC Group by 1.2% during the first quarter. Legal & General Group Plc now owns 25,087 shares of the health services provider’s stock worth $1,353,000 after acquiring an additional 290 shares during the period. Thrivent Financial For Lutherans lifted its holdings in LHC Group by 4.1% during the first quarter. Thrivent Financial For Lutherans now owns 8,380 shares of the health services provider’s stock worth $452,000 after acquiring an additional 330 shares during the period. Finally, Vanguard Group Inc. lifted its holdings in LHC Group by 3.9% during the first quarter. Vanguard Group Inc. now owns 1,432,008 shares of the health services provider’s stock worth $77,185,000 after acquiring an additional 54,279 shares during the period. Institutional investors and hedge funds own 87.32% of the company’s stock.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with Analyst Ratings Network's FREE daily email newsletter.